A mouse B16 melanoma mutant deficient in glycolipids.
Mouse B16 melanoma cell line, GM-95 (formerly designated as MEC-4), deficient in sialyllactosylceramide was examined for its primary defect. Glycolipids from the mutant cells were analyzed by high-performance TLC. No glycolipid was detected in GM-95 cells, even when total lipid from 10(7) cells was...
Guardado en:
| Publicado en: | Proc Natl Acad Sci U S A |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
National Academy of Sciences
1994
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC43438/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8146177/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.91.7.2703 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|